155 related articles for article (PubMed ID: 2524119)
21. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
22. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane.
McGoff MA; Allen BT; Der T; Sicard GA; Santoro SA
Thromb Res; 1989 Sep; 55(6):695-707. PubMed ID: 2506670
[TBL] [Abstract][Full Text] [Related]
25. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
26. Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Nidorf SM; Sturm M; Strophair J; Kendrew PJ; Taylor RR
Cardiovasc Res; 1989 Apr; 23(4):273-8. PubMed ID: 2590911
[TBL] [Abstract][Full Text] [Related]
27. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
Mayfield RK; Halushka PV; Wohltmann HJ; Lopes-Virella M; Chambers JK; Loadholt CB; Colwell JA
Diabetes; 1985 Nov; 34(11):1127-33. PubMed ID: 3930325
[TBL] [Abstract][Full Text] [Related]
28. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
[TBL] [Abstract][Full Text] [Related]
29. Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs.
Bodzenta-Lukaszyk A; Krupiński K; Dabrowski S; Bielawiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):479-82. PubMed ID: 2465957
[TBL] [Abstract][Full Text] [Related]
30. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin.
Pasqui AL; Capecchi PL; Ceccatelli L; Mazza S; Gistri A; Laghi Pasini F; Di Perri T
Thromb Res; 1991 Jan; 61(2):113-22. PubMed ID: 1902328
[TBL] [Abstract][Full Text] [Related]
31. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
32. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
McDaniel HG; Maddox WT; Poon MC; Rogers WJ; Rackley CE
Am J Cardiol; 1983 Nov; 52(8):965-8. PubMed ID: 6416046
[TBL] [Abstract][Full Text] [Related]
33. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Chignard M; Wal F; Lefort J; Vargaftig BB
Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
[TBL] [Abstract][Full Text] [Related]
34. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
[TBL] [Abstract][Full Text] [Related]
35. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
[TBL] [Abstract][Full Text] [Related]
36. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
Bailey SR; Andrews MJ; Elliott J; Cunningham F
Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
38. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
39. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Kornecki E; Ehrlich YH; Lenox RH
Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
[TBL] [Abstract][Full Text] [Related]
40. Effects of ethanol on platelet function.
Hillbom M; Kangasaho M; Löwbeer C; Kaste M; Muuronen A; Numminen H
Alcohol; 1985; 2(3):429-32. PubMed ID: 4026960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
